From Name:
From Email:
To Name:
To Email:

Optional Message:

Interleukin Genetics to study impact of genetic test for periodontal disease

from Dentistry Today

Interleukin Genetics, a U.S. company that develops and markets a line of genetic tests for chronic diseases and health-related conditions, has announced that it will conduct a clinical study to assess the impact of its PerioPredict Genetic Risk Test on dental patient engagement for greater preventive dental care. The study will build on the company's evidence base in support of the medical and economic value of the PerioPredict genetic testing platform. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063